White Paper | Conference on Clinical Cancer Research 2012 – Panel 3 | Design of a Disease-Specific Master Protocol | April 7, 2016 Share
White Paper | Conference on Clinical Cancer Research 2012 – Panel 2 | Developing Standards for Breakthrough Therapy Designation | April 7, 2016 Share
White Paper | Friends/Alexandria Forum 2013 – A Blueprint for Drug/Diagnostic Co-development: Breakthrough Therapies | April 7, 2016 Share
White Paper | Conference on Clinical Cancer Research 2013 – Panel 3 | Optimizing Dosing of Oncology Drugs | April 7, 2016 Share
White Paper | Conference on Clinical Cancer Research 2013 – Panel 1 | Facilitating Development of Immunotherapies | April 7, 2016 Share
White Paper | Friends/Alexandria Forum 2014 – A Blueprint for Drug/Diagnostic Co-development: Next-Generation Sequencing (NGS) White Paper | April 7, 2016 Share
White Paper | Conference on Clinical Cancer Research 2014 – Panel 3 | Considerations for Summary Review of Supplemental NDA/BLA Submissions in Oncology | April 7, 2016 Share
White Paper | Conference on Clinical Cancer Research 2014 – Panel 2 | Improving Evidence Developed from Population-Level Experience with Targeted Agents | April 7, 2016 Share
White Paper | Conference on Clinical Cancer Research 2014 – Panel 1 | The Role of Non-Randomized Trials for the Evaluation of Oncology Drugs | April 7, 2016 Share
White Paper | Friends/Alexandria Forum 2015 – Blueprint for Drug/Diagnostic Development: Genetic Databases | April 7, 2016 Share
